Urine pH as a Predictor of Diabetes
This study has been completed.
Sponsor:
North Shore Long Island Jewish Health System
Collaborator:
Staten Island University Hospital
Information provided by (Responsible Party):
Suzanne El-Sayegh, North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:
NCT01017848
First received: November 19, 2009
Last updated: June 10, 2013
Last verified: June 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Urine pH has been lately linked to insulin resistance. The early phase of Diabetes Mellitus involves insulin resistance. Thus, the investigators want to check if a simple cheap study like a urine analysis that can predict diabetes.
| Condition |
|---|
|
Diabetes |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Retrospective |
| Official Title: | Urine pH as a Predictor of Diabetes |
Resource links provided by NLM:
Further study details as provided by North Shore Long Island Jewish Health System:
Primary Outcome Measures:
- development of diabetes using a predicting formula [ Time Frame: 10 years ] [ Designated as safety issue: No ]
| Enrollment: | 92 |
| Study Start Date: | November 2009 |
| Study Completion Date: | September 2010 |
| Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Adults, nondiabetics
adults who are nondiabetic, no CKD, no urinary tract infection, no bladder dysfunction
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
adult inpatients, nondiabetic, no CKD, no urine infection, no UTO
Criteria
Inclusion Criteria:
- age > 18
Exclusion Criteria:
- diabetes
- CKD
- urine infection
- UTO
- bladder dysfunction
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01017848
Locations
| United States, New York | |
| Staten Island University Hospital | |
| Staten Island, New York, United States, 10305 | |
Sponsors and Collaborators
North Shore Long Island Jewish Health System
Staten Island University Hospital
Investigators
| Principal Investigator: | Suzanne El-Sayegh, MD | SIUH |
More Information
No publications provided
| Responsible Party: | Suzanne El-Sayegh, Associate Chair of Medicine, North Shore Long Island Jewish Health System |
| ClinicalTrials.gov Identifier: | NCT01017848 History of Changes |
| Other Study ID Numbers: | 09-031 |
| Study First Received: | November 19, 2009 |
| Last Updated: | June 10, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by North Shore Long Island Jewish Health System:
|
diabetes urine pH insulin resistance metabolic syndrome development of diabetes |
Additional relevant MeSH terms:
|
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013